Life ScienceCompany
Who owns Inozyme Pharma?
Inozyme Pharma is owned by BioMarin Pharmaceutical. It was acquired in 2025.
Inozyme Pharma is owned by BioMarin Pharmaceutical. It was acquired in 2025.
321 Summer Street, Suite 400,
Boston, Massachusetts
02210
United States,
(857) 330-4340
www.inozyme.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2025-05-16 | BioMarin Pharmaceutical | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
